John Celebi
2023
In 2023, John Celebi earned a total compensation of $1M as President and Chief Executive Officer at Sensei Biotherapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $285,743 |
|---|---|
| Option Awards | $99,554 |
| Salary | $532,167 |
| Stock Awards | $30,459 |
| Other | $64,366 |
| Total | $1,012,289 |
Celebi received $532.2K in salary, accounting for 53% of the total pay in 2023.
Celebi also received $285.7K in non-equity incentive plan, $99.6K in option awards, $30.5K in stock awards and $64.4K in other compensation.
Rankings
In 2023, John Celebi's compensation ranked 1,202nd out of 3,006 executives tracked by ExecPay. In other words, Celebi earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,202 out of 3,006 | 60th |
Division Manufacturing | 717 out of 1,650 | 57th |
Major group Chemicals And Allied Products | 482 out of 918 | 48th |
Industry group Drugs | 470 out of 881 | 47th |
Industry Pharmaceutical Preparations | 325 out of 637 | 49th |
Source: SEC filing on April 29, 2024.
Celebi's colleagues
We found two more compensation records of executives who worked with John Celebi at Sensei Biotherapeutics in 2023.